Gingival Crevicular Fluid Biomarkers During Periodontitis Progression and After Periodontal Treatment
Flavia Teles,Lynn Martin,Michele Patel,Weiming Hu,Kyle Bittinger,Michael J. Kallan,Ganesh Chandrasekaran,Andrew J. Cucchiara,William V. Giannobile,Danielle Stephens,Alpdogan Kantarci
DOI: https://doi.org/10.1111/jcpe.14061
IF: 7.478
2024-09-16
Journal Of Clinical Periodontology
Abstract:Objective To identify gingival crevicular fluid (GCF)‐derived inflammatory markers of periodontitis progression and periodontal treatment impact. Methods Periodontally healthy (H; n = 112) and periodontitis (P; n = 302) patients were monitored bi‐monthly for 1 year without therapy. Periodontitis patients were re‐examined 6 months after non‐surgical periodontal therapy (NSPT). Levels of 64 biomarkers were measured in the GCF samples collected at each visit from progressing (n = 12 sites in H; n = 76 in P) and stable (n = 100 in H, n = 225 in P) sites. Clinical parameters and log‐transformed analyte levels were averaged within clinical groups at each time point and analysed using linear mixed models. Results During monitoring, progressing sites had significantly higher levels of IL‐1β, MMP‐8, IL‐12p40, EGF and VEGF. MMP‐9 and Periostin were significantly more elevated in stable sites. Distinct cytokine profiles were observed based on baseline PD. Treatment led to significant reductions in Eotaxin, Flt‐3L, GDF‐15, GM‐CSF, IL‐1β, IL‐17, MIP‐1d, RANTES and sCD40L, and increases in IP‐10 and MMP‐9. Conclusion Distinct cytokine signatures observed in stable and progressing sites were maintained over time in the absence of treatment and significantly affected by NSPT.
dentistry, oral surgery & medicine